Fundraising FoxHealthX Ventures — 2015 Investments
4 investments dated 2015 · listed companies and verified rows first · show all
Catalyze develops, finances, builds, owns, and operates on-site renewable energy systems — combining solar, storage, and EV charging — for commercial and industrial real estate owners and operators across national portfolios in the US, with no upfront capital cost to the property owner.
CleantechClimate TechEnergyPropTechSaaSMadison, US
Mohan Balachandran(Executive Officer, Director)Travis Good(Executive Officer, Director)
BoardJames Burgum(Director)inDon Layden(Director)
Board seatMark Bakken· per SEC Form D · $4M raise · filed Apr 2015
Co-investorsEnCap Energy TransitionInnosphere VenturesArthur VenturesChicago VenturesLewis & Clark Ventures
Redox provides healthcare data integration infrastructure that enables organizations to ingest EHR and legacy data into cloud-based clinical repositories and third-party healthcare applications.
Cloud ComputingData & InfrastructureDigital HealthEnterprise SoftwareHealthtechMadison, US
Niko Skievaski(Founder)inTrip Hofer(CEO)inJames Lloyd(Founder)Luke Bonney(Founder)
Board seatMark Bakken· per SEC Form D
Co-investors.406 VenturesAvenir Growth CapitalBattery VenturesDreamit VenturesFlybridge Capital PartnersIntermountain Health+4 more
Health iPASS is a patient engagement platform for healthcare providers that integrates with practice management (PM) and EHR systems to handle pre-visit communication, digital intake, eligibility verification, AI-powered self-scheduling, and automated payment collection.
Digital HealthEnterprise SoftwareHealthtechSaaSNaperville, US
Rajesh Voddiraju(Executive Officer, Director, Promoter)inThirumal Nellutla(Director, Promoter)
Co-investorsFCA Venture PartnersHealthy VenturesWaterline Ventures
A U.S. developer of a mobile mental health application grounded in cognitive behavioral therapy.
HealthtechSan Francisco, US
Chris GoettelDale Beermann
Co-investors500 GlobalLEO Innovation Lab
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.